The New Emphasis of Lipoprotein Particles for Cardiovascular Risk Assessment

Presented by Jan Troup, Ph.D.

Learning Objectives:

• Addressing the new emphasis of lipoprotein particles over cholesterol for lipid management
• ATP IV has been canceled: Particles are in  and cholesterol is out
• Review the enhancements of the LPP technology
• Learn how lipoprotein subgroup measurement provides a better risk assessment and therapeutic approach